Skip to main content
. 2022 Apr 26;2022:6560154. doi: 10.1155/2022/6560154

Figure 2.

Figure 2

Relationship among RAPGEF2, immune infiltration tumor immune dysfunction exclusion, and immunotherapy response to HCC patients. (a) The scores of 16 immune cells. (b) The scores of 13 immune-related functions. (c) The value of the tumor immune dysfunction and exclusion (TIDE). (d) The response to immunotherapy (P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ns: no significant).